Hypoglycaemic effects of antidiabetic drugs in streptozotocin-nicotinamide- induced mildly diabetic and streptozotocin-induced severely diabetic rats

Basic and Clinical Pharmacology and Toxicology

Volumn 103, Issue 6, 2008, Pages 560-568

  Tahara, Atsuo ^a   Matsuyama Yokono, Akiko ^a   Nakano, Ryosuke ^a   Someya, Yuka ^a   Shibasaki, Masayuki ^a  

^a ASTELLAS PHARMA INC   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GLIBENCLAMIDE; INSULIN; METFORMIN; NOVOLIN R 100; SITAGLIPTIN; UNCLASSIFIED DRUG; VOGLIBOSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFECT; HYPERGLYCEMIA; IMPAIRED GLUCOSE TOLERANCE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; RAT; STREPTOZOCIN DIABETES;

ANIMALS; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; GLUCOSE TOLERANCE TEST; HYPOGLYCEMIC AGENTS; INSULIN; MALE; NIACINAMIDE; RATS; RATS, SPRAGUE-DAWLEY; STREPTOZOCIN;

RATTUS;

EID: 56049099293     PISSN: 17427835     EISSN: 17427843     Source Type: Journal    
DOI: 10.1111/j.1742-7843.2008.00321.x     Document Type: Article

References (27)

1. Srinivasan K, Ramarao P. Animal models in type 2 diabetes research: an overview. Indian J Med Res 2007 125 : 451 72.
2. Ladriere L, Malaisse-Lagae F, Fuhlendorff J, Malaisse WJ. Repaglinide, glibenclamide and glimepiride administration to normal and hereditarily diabetic rats. Eur J Pharmacol 1997 335 : 227 34.
3. Efanov AM, Appelskog IB, Abdel-Halim SM, Khan A, Branstrom R, Larsson O et al. Insulinotropic activity of the imidazoline derivative RX871024 in the diabetic GK rat. Am J Physiol Endocrinol Metab 2002 282 : E117 24.
4. Portha B, Serradas P. Improvement in glucose-induced insulin secretion in diabetic rats after long-term gliclazide treatment: a comparative study using different models of non-insulin-dependent diabetes mellitus induced by neonatal streptozotocin. Am J Med 1991 90 : S15 S21.
5. Balkan B, Kwasnik L, Miserendino R, Holst JJ, Li X. Inhibition of dipeptidyl peptidase IV with NVP-DPP728 increases plasma GLP-1 (7-36 amide) concentrations and improves oral glucose tolerance in obese Zucker rats. Diabetologia 1999 42 : 1324 31.
6. Mine T, Miura K, Kitahara Y, Okano A, Kawamori R. Nateglinide suppresses postprandial hypertriglyceridemia in Zucker fatty rats and Goto-Kakizaki rats: comparison with voglibose and glibenclamide. Biol Pharma Bull 2002 25 : 1412 6.
7. Farrar NS, Chambers NJ, Carlsson AR, Denyer G, Johnston GA. Effect of a series of novel sulphonylthioureas on glucose tolerance in the obese fa/fa Zucker rat. Clin Exp Pharmacol Physiol 2001 28 : 386 91.
8. Schnedl WJ, Ferber S, Johnson JH, Newgard CB. STZ transport and cytotoxicity. Specific enhancement in GLUT2-expressing cells. Diabetes 1994 43 : 1326 33.
9. Turk J, Corbett JA, Ramanadham S, Bohrer A, McDaniel ML. Biochemical evidence for nitric oxide formation from streptozotocin in isolated pancreatic islets. Biochem Biophys Res Commun 1993 197 : 1458 64.
10. Burkart V, Wang ZQ, Radons J, Heller B, Herceg Z, Stingl L et al. Mice lacking the poly(ADP-ribose) polymerase gene are resistant to pancreatic beta-cell destruction and diabetes development induced by streptozotocin. Nat Med 1999 5 : 314 9.
11. Oguri S, Motegi K, Endo Y. Augmented lipopolysaccharide-induction of the histamine-forming enzyme in streptozotocin-induced diabetic mice. Biochim Biophys Acta 2003 1637 : 83 90.
12. LeDoux SP, Hall CR, Forbes PM, Patton NJ, Wilson GL. Mechanisms of nicotinamide and thymidine protection from alloxan and streptozocin toxicity. Diabetes 1988 37 : 1015 9.
13. Masiello P, Broca C, Gross R, Roye M, Manteghetti M, Hillaire-Buys D et al. Experimental NIDDM: development of a new model in adult rats administered streptozotocin and nicotinamide. Diabetes 1998 47 : 224 9.
14. Ichikawa K, Yamato T, Ojima K, Tsuji A, Ishikawa K, Kusama H et al. Effect of KAD-1229, a novel hypoglycaemic agent, on plasma glucose levels after meal load in type 2 diabetic rats. Clin Exp Pharmacol Physiol 2002 29 : 423 7.
15. Holst JJ, Deacon CF. Glucagon-like peptide 1 and inhibitors of dipeptidyl peptidase IV in the treatment of type 2 diabetes mellitus. Curr Opin Pharmacol 2004 4 : 589 96.
16. Mentlein R, Gallwitz B, Schimdt WE. Dipeptidyl-peptidase IV hydrolyses gastric inhibitory polypeptide, glucagon-like peptide-1(7-36)amide, peptide histidine methionine and is responsible for their degradation in human serum. Eur J Biochem 1993 214 : 829 35.
17. Ahren B, Holst JJ, Martensson H, Balkan B. Improved glucose tolerance and insulin secretion by inhibition of dipeptidyl peptidase IV in mice. Eur J Pharmacol 2000 404 : 239 45.
18. Casirola DM, Ferraris RP. Alpha-glucosidase inhibitors prevent diet-induced increases in intestinal sugar transport in diabetic mice. Metabolism 2006 55 : 832 41.
19. Matsuo T, Odaka H, Ikeda H. Effect of an intestinal disaccharidase inhibitor (AO-128) on obesity and diabetes. Am J Clin Nutr 1992 55 : 314S 7.
20. Odaka H, Shino A, Ikeda H, Matsuo T. Antiobesity and antidiabetic actions of a new potent disaccharidase inhibitor in genetically obese-diabetic mice, KKA(y). J Nutr Sci Vitaminol 1992 38 : 27 37.
21. Azuma K, Toyofuku Y, Iesaki T, Otsuka A, Tanaka A, Mita T et al. Acarbose, an alpha-glucosidase inhibitor, improves endothelial dysfunction in Goto-Kakizaki rats exhibiting repetitive blood glucose fluctuation. Biochem Biophys Res Commun 2006 345 : 688 93.
22. Fujita H, Fujishima H, Koshimura J, Hosoba M, Yoshioka N, Shimotomai T et al. Effects of antidiabetic treatment with metformin and insulin on serum and adipose tissue adiponectin levels in db/db mice. Endocr J 2005 52 : 427 33.
23. Cheng JT, Huang CC, Liu IM, Tzeng TF, Chang CJ. Novel mechanism for plasma glucose-lowering action of metformin in streptozotocin-induced diabetic rats. Diabetes 2006 55 : 819 25.
24. El-Atat F, McFarlane SI, Sowers JR. Diabetes, hypertension, and cardiovascular derangements: pathophysiology and management. Curr Hypertens Rep 2004 6 : 215 23.
25. Santeusanio F, Di Loreto C, Lucidi P, Murdolo G, De Cicco A, Parlanti N et al. Diabetes and exercise. J Endocrinol Invest 2003 26 : 937 40.
26. Srinivasan K, Viswanad B, Asrat L, Kaul CL, Ramarao P. Combination of high-fat diet-fed and low-dose streptozotocin rat: a model for type 2 diabetes and pharmacological screening. Pharmacol Res 2005 52 : 313 20.
27. Suryanarayana P, Saraswat M, Mrudula T, Krishna TP, Krishnaswamy K, Reddy GB. Curcumin and turmeric delay streptozotocin-induced diabetic cataract in rats. Invest Ophthalmol Vis Sci 2005 46 : 2092 9.